V VAXCYTE INC
| Market Cap | $8.48B |
| P/E Ratio | — |
| Forward P/E | -8.01 |
| Dividend Yield | — |
| Beta | 1.39 |
| 52W Range | $28.04 - $63.04 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Lee Ainslie Maverick Capital | 0.67% | $62.48M | 1,354,237 | Add 5.01% |
Insider Trading
| Insider Name of the company insider who made the trade 13 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Wassil JimCHIEF OPERATING OFFICER | Sale | 838 | $58.93 | $49.39K | 01 Apr 2026 | 01 Apr 2026 |
| Wassil JimCHIEF OPERATING OFFICER | Sale | 1,412 | $58.14 | $82.09K | 01 Apr 2026 | 01 Apr 2026 |
| Cowan ElviaSVP, Finance & CAO | Sale | 405 | $56.26 | $22.79K | 17 Mar 2026 | 17 Mar 2026 |
| Cowan ElviaSVP, Finance & CAO | Sale | 1,487 | $55.39 | $82.36K | 17 Mar 2026 | 17 Mar 2026 |
| Cowan ElviaSVP, Finance & CAO | Sale | 2,500 | $58.59 | $146.48K | 11 Mar 2026 | 09 Mar 2026 |
| Wassil JimCHIEF OPERATING OFFICER | Sale | 4,968 | $59.16 | $293.91K | 10 Mar 2026 | 09 Mar 2026 |
| Wassil JimCHIEF OPERATING OFFICER | Sale | 2,427 | $58.32 | $141.53K | 10 Mar 2026 | 09 Mar 2026 |
| Dhaliwal Harpreet S.Chief Technical Ops Officer | Sale | 9,743 | $46.69 | $454.89K | 31 Dec 2025 | 02 Jan 2026 |
| Harpreet S. DhaliwalChief Technical Ops Officer | Sale | 9,743 | $46.69 | $454.89K | 31 Dec 2025 | 02 Jan 2026 |
| Cowan ElviaSVP, FINANCE | Sale | 6,716 | $47.94 | $321.93K | 23 Dec 2025 | 29 Dec 2025 |
| Cowan ElviaSVP, FINANCE | Sale | 4,907 | $47.90 | $235.04K | 23 Dec 2025 | 29 Dec 2025 |
| Elvia CowanSVP, FINANCE | Sale | 4,907 | $47.90 | $235.04K | 23 Dec 2025 | 29 Dec 2025 |
| Elvia CowanSVP, FINANCE | Sale | 6,716 | $47.94 | $321.93K | 23 Dec 2025 | 29 Dec 2025 |
Frequently Asked Questions
What is PCVX stock price today?
VAXCYTE INC (PCVX) is currently trading at $58.38. The stock has a 52-week range of $28.04 to $63.04 and a market capitalization of $8.48B.
Is PCVX a good stock to buy in 2026?
VAXCYTE INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +91.0%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling PCVX stock?
There have been 13 insider transactions for PCVX in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has PCVX stock performed over the past year?
VAXCYTE INC (PCVX) has returned +91.0% over the past 12 months. The stock traded between $28.04 and $63.04 during this period, and is currently at $58.38.
Which hedge funds own PCVX (VAXCYTE INC)?
1 tracked hedge funds currently hold PCVX in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is PCVX's market cap and valuation?
VAXCYTE INC (PCVX) has a market capitalization of $8.48B. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is PCVX's revenue and profitability?
VAXCYTE INC reported revenue of N/A with net income of N/A and a profit margin of N/A. The stock has a beta of 1.39.
What sector is PCVX in and who are its biggest institutional holders?
VAXCYTE INC (PCVX) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.